1. Share Prices

  2. Hvivo PLC (HVO)

6.50p+0.00 (+0.00%)05 Nov 2025, 16:11
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Hvivo PLC Fundamentals

Company NameHvivo PLCLast Updated2025-11-05
IndustryBiotechnologySectorHealthcare
Shares in Issue687.216 mMarket Cap£44.67 m
PE Ratio8.44Dividend per Share£0.00
Dividend Yield3.08Dividend Cover7.75
EPS£0.02EPS Growth (%)-0.35
PEG0DPS Growth (%)0
Debt Ratio0.1716Debt Equity Ratio0.2796
Asset Equity Ratio1.9636Cash Equity Ratio0.5338
Quick Ratio1.4590Current Ratio1.60
Price To Book Value1.0239ROCE0

Hvivo PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2025-05-152025-06-11GBP0.0020
Prelim2024-04-182024-05-20GBP0.0020

Hvivo PLC Company Financials

Assets202420232022
Tangible Assets£19.30 m£20.04 m£3.12 m
Intangible Assets£5.70 m£5.67 m£6.02 m
Investments000
Total Fixed Assets£28.66 m£31.22 m£9.15 m
Stocks£804,000.00£426,000.00£499,000.00
Debtors£13.96 m£13.20 m£12.30 m
Cash & Equivalents£44.18 m£36.97 m£28.44 m
Other Assets£3.66 m£5.52 m0
Total Assets£88.89 m£83.23 m£51.38 m
Liabilities202420232022
Creditors within 1 year£31.91 m£35.18 m£29.77 m
Creditors after 1 year£12.30 m£13.72 m£1.40 m
Other Liabilities000
Total Liabilities£44.22 m£48.90 m£31.16 m
Net assets£44.67 m£34.33 m£20.22 m
Equity202420232022
Called up share capital£680,000.00£680,000.00£671,000.00
Share Premium£516,000.00£516,000.00£4,000.00
Profit / Loss£13.29 m£11.15 m-£365,000.00
Other Equity£44.67 m£34.33 m£20.22 m
Preference & Minorities000
Total Capital Employed£44.67 m£34.33 m£20.22 m
Ratios202420232022
Debt Ratio£0.19£0.26£0.04
Debt-to-Equity£0.23£0.35£0.04
Assets / Equity1.96361.96361.9636
Cash / Equity0.53380.53380.5338
EPS£0.02£0.02£0.01
Cash Flow202420232022
Cash from operating activities£10.34 m£17.24 m£15.98 m
Cashflow before financing£7.93 m£12.54 m£14.15 m
Increase in Cash£7.27 m£8.54 m£12.79 m
Income202420232022
Turnover£62.73 m£56.04 m£48.48 m
Cost of sales000
Gross Profit000
Operating Profit£12.86 m£10.10 m£6.02 m
Pre-Tax profit£13.29 m£11.15 m-£365,000.00

Hvivo PLC Company Background

SectorHealthcare
ActivitieshVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which is involved in the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medicaldevice organizations.
Latest Interim Date23 Sep 2025
Latest Fiscal Year End Date10 Apr 2025

Hvivo PLC Directors

AppointedNamePosition
2020-01-20Mr. Michael P Ryan Non-Executive Director,Senior Independent Director
2013-06-18Mr. Adam ReynoldsNon-Executive Director
2014-04-14Mr. Paul Andrew Peter FoulgerExecutive Director,Finance Director and Company Secretary
2016-01-08Mr. David Eric EvansNon-Executive Director,Chairman
2020-07-06Mr. Anthony Francis Richardson Executive Director,Corporate Development Director
2019-06-13Mr. Paul Francis Kennedy Non-Executive Director
2018-12-11Mr. Allan Leigh Wood Executive Director,Chairman
2025-06-05Mr. Cathal Martin FrielNon-Executive Director,Chairman
2019-06-11Ms. Mary Blake Sheahan Non-Executive Director
2017-08-16Ms. Gracielle Anna Maria Beijerbacht-SchutjensExecutive Director,Chief Operating Officer
2018-03-21Mr. Jonathan David HartshornExecutive Director,Chief Financial Officer
2020-05-04Mr. Mark Robert WarneNon-Executive Director
2017-04-06Mr. Kees GroenExecutive Director
2020-01-20Dr. Christian Bernard MillaExecutive Director,Chief Operating Officer
2025-05-01Professor Brendan BuckleyNon-Executive Director
2020-01-20Dr. Maurice Treacy Executive Director
2025-05-01Mr. Yamin Mohammed KhanExecutive Director,Chief Executive Officer
2025-04-10Mr. Stephen PinkertonExecutive Director,Chief Financial Officer

Hvivo PLC Contact Details

Company NamehVIVO PLC
Address1 Berkeley Street, London, W1J 8DJ
Telephone+353 15373269
Websitehttps://www.hvivo.com

Hvivo PLC Advisors

Nominated AdviserCenkos Securities
Phone+44 2073978900
StockbrokerCenkos Securities
Phone+44 2073978900
StockbrokerHybridan LLP
Phone+44 203764 2341
Fax+44 2076001586
BankUlster Bank Group
AuditorJeffreys Henry LLP
Phone+44 2073092222
Fax+44 2073092309
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
RegistrarS.L.C Registrars Ltd
Phone+44 1903706150
SolicitorBPE Solicitors LLP
Phone+44 1242224433
Fax+44 1242574285

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Ceres Power Holdings PLC371.8018.86
Metro Bank Holdings PLC118.008.26
Bluefield Solar Income Fund Limited76.906.51
Aston Martin Lagonda Global Holdings PLC61.705.65
Trainline PLC267.205.03
4Imprint Group PLC3,355.004.52

Fallers

CompanyPrice% Chg
Playtech PLC235.00-5.05
Tp Icap Group PLC251.00-4.20
Oxford Biomedica PLC660.00-3.23
Qinetiq Group PLC461.00-3.03
Victrex PLC620.00-2.97
Watches Of Switzerland Group PLC390.00-2.21